These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38763874)
1. [Clinical characteristics and prognosis of 5 children with maturity onset of diabetes of the young 12 subtype]. Cao BY; Miao M; Wang DM; Meng X; Gong CX Zhonghua Er Ke Za Zhi; 2024 Jun; 62(6):530-534. PubMed ID: 38763874 [No Abstract] [Full Text] [Related]
2. Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy. Reilly F; Sanchez-Lechuga B; Clinton S; Crowe G; Burke M; Ng N; Colclough K; Byrne MM Diabet Med; 2020 May; 37(5):876-884. PubMed ID: 31562829 [TBL] [Abstract][Full Text] [Related]
3. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA; Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274 [TBL] [Abstract][Full Text] [Related]
4. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892 [TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and genetic analysis of children and adolescents with monogenic diabetes]. Fang J; Zhang P; Feng Y; Ding S; Yan L; Li H Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jul; 41(7):783-789. PubMed ID: 38946358 [TBL] [Abstract][Full Text] [Related]
6. A case report of maturity-onset diabetes of the young (MODY12) in a Chinese Han patient with a novel ABCC8 gene mutation. Wang Y; Kang C; Tong Q; Wang H; Zhang R; Qiao Q; Sang Q; Wang X; Wang J; Xu J Medicine (Baltimore); 2022 Dec; 101(49):e32139. PubMed ID: 36626423 [TBL] [Abstract][Full Text] [Related]
7. Lin L; Quan H; Chen K; Chen D; Lin D; Fang T Front Endocrinol (Lausanne); 2020; 11():645. PubMed ID: 33013711 [TBL] [Abstract][Full Text] [Related]
8. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group. Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524 [TBL] [Abstract][Full Text] [Related]
9. [Maturity-onset diabetes of the young 2 with a novel mutation of glucokinase gene in a Chinese boy and the clinical follow-up]. Li X; Liu L; Liang C; Sheng H; Zhao X Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):867-71. PubMed ID: 25582477 [TBL] [Abstract][Full Text] [Related]
10. Case Report: A Novel Tang C; Meng L; Zhang P; Liang X; Dang C; Liang H; Wu J; Lan H; Qin Y Front Endocrinol (Lausanne); 2021; 12():758723. PubMed ID: 35002955 [TBL] [Abstract][Full Text] [Related]
11. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey. Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595 [TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the ABCC8 gene causing maturity-onset diabetes of the young: A case report. Guo Y; Chen Y; Liang W; Zeng L; Hu F; Zeng Y; Cong L Clin Med (Lond); 2024 Mar; 24(2):100033. PubMed ID: 38513803 [TBL] [Abstract][Full Text] [Related]
13. U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study. Diabetes; 1985 Aug; 34(8):793-8. PubMed ID: 2862087 [TBL] [Abstract][Full Text] [Related]
14. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. Turner RC; Cull CA; Frighi V; Holman RR JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389 [TBL] [Abstract][Full Text] [Related]
15. Clinical presentation and long-term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria. Warncke K; Eckert A; Kapellen T; Kummer S; Raile K; Dunstheimer D; Grulich-Henn J; Woelfle J; Wenzel S; Hofer SE; Dost A; Holl RW Pediatr Diabetes; 2022 Nov; 23(7):999-1008. PubMed ID: 35822653 [TBL] [Abstract][Full Text] [Related]
16. Neonatal diabetes caused by the heterozygous Pro1198Leu mutation in the ABCC8 gene in a male infant: 6-year clinical course. Uraki S; Furuta H; Miyawaki M; Matsutani N; Shima Y; Iwamoto M; Matsuno S; Morita S; Furuta M; Doi A; Iwakura H; Ariyasu H; Nishi M; Suzuki H; Akamizu T J Diabetes Investig; 2020 Mar; 11(2):502-505. PubMed ID: 31390154 [TBL] [Abstract][Full Text] [Related]
17. ABCC8 variants in MODY12: Review of the literature and report of a case with severe complications. Timmers M; Dirinck E; Lauwers P; Wuyts W; De Block C Diabetes Metab Res Rev; 2021 Nov; 37(8):e3459. PubMed ID: 34014594 [TBL] [Abstract][Full Text] [Related]
18. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Umpierrez GE; Clark WS; Steen MT Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964 [TBL] [Abstract][Full Text] [Related]
19. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T; Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR; Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]